Samuel Dagogo-Jack (Sam Dagogo-Jack)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 46

Top Topics

African American

Glycemic Control

Ejection Fraction

Top Venues

BMJ open diabetes research & care

Journal of the Endocrine Society

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Lekshmi Nair, Peace Asuzu, Samuel Dagogo-Jack
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes. Journal of the Endocrine Society 8 (7) (2024)
Matthew Everett, Natasha Rushing, Peace Asuzu, Jim Wan, Samuel Dagogo-Jack
Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes. BMJ open diabetes research & care 12 (1) (2024)
Lekshmi Nair, Peace Asuzu, Samuel Dagogo-Jack
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes. Journal of the Endocrine Society 8 (7) (2024)
Matthew Everett, Natasha Rushing, Peace Asuzu, Jim Wan, Samuel Dagogo-Jack
Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes. BMJ open diabetes research & care 12 (1) (2024)
Matthew Everett, Natasha Rushing, Peace Asuzu, Jim Wan, Samuel Dagogo-Jack
Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes. BMJ open diabetes research & care 12 (1) (2024)
Matthew Everett, Natasha Rushing, Peace Asuzu, Jim Wan, Samuel Dagogo-Jack
Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes. BMJ open diabetes research & care 12 (1) (2024)
Lekshmi Nair, Peace Asuzu, Samuel Dagogo-Jack
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes. Journal of the Endocrine Society 8 (7) (2024)
Lekshmi Nair, Peace Asuzu, Samuel Dagogo-Jack
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes. Journal of the Endocrine Society 8 (7) (2024)
Lekshmi Nair, Peace Asuzu, Samuel Dagogo-Jack
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes. Journal of the Endocrine Society 8 (7) (2024)
Matthew Everett, Natasha Rushing, Peace Asuzu, Jim Wan, Samuel Dagogo-Jack
Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes. BMJ open diabetes research & care 12 (1) (2024)
Erin S LeBlanc, Anastassios G Pittas, Jason Nelson, Ranee Chatterjee, Neda Rasouli, Mary K Rhee, Richard E Pratley, Cyrus V Desouza, Lisa M Neff, Anne M Peters, Samuel Dagogo-Jack, Daniel S Hsia, null null
Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial. BMJ open diabetes research & care 12 (1) (2024)
Samuel Dagogo-Jack, Peace Asuzu, Jim Wan, Richard Grambergs, Frankie Stentz, Nawajes A Mandal
Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort. The Journal of clinical endocrinology and metabolism (2024)
Brigida Colon-Barreto, Peace Asuzu, Sotonte Ebenibo, Samuel Dagogo-Jack
Association of Hepatic Steatosis and Fibrosis Indices With Insulin Sensitivity and Inflammation in the POP-ABC Study. Journal of the Endocrine Society 8 (4) (2024)
Brigida Colon-Barreto, Peace Asuzu, Sotonte Ebenibo, Samuel Dagogo-Jack
Association of Hepatic Steatosis and Fibrosis Indices With Insulin Sensitivity and Inflammation in the POP-ABC Study. Journal of the Endocrine Society 8 (4) (2024)
Erin S LeBlanc, Anastassios G Pittas, Jason Nelson, Ranee Chatterjee, Neda Rasouli, Mary K Rhee, Richard E Pratley, Cyrus V Desouza, Lisa M Neff, Anne M Peters, Samuel Dagogo-Jack, Daniel S Hsia, null null
Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial. BMJ open diabetes research & care 12 (1) (2024)
Samuel Dagogo-Jack, Peace Asuzu, Jim Wan, Richard Grambergs, Frankie Stentz, Nawajes A Mandal
Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort. The Journal of clinical endocrinology and metabolism (2024)
Brigida Colon-Barreto, Peace Asuzu, Sotonte Ebenibo, Samuel Dagogo-Jack
Association of Hepatic Steatosis and Fibrosis Indices With Insulin Sensitivity and Inflammation in the POP-ABC Study. Journal of the Endocrine Society 8 (4) (2024)
Lekshmi Nair, Peace Asuzu, Samuel Dagogo-Jack
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes. Journal of the Endocrine Society 8 (7) (2024)
Joseph M Kim, Deepak L Bhatt, Samuel Dagogo-Jack, David Z I Cherney, Francesco Cosentino, Darren K McGuire, Richard E Pratley, Chih-Chin Liu, Nilo B Cater, Robert C Frederich, James P Mancuso, Christopher P Cannon
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease. Diabetes, obesity & metabolism (2023)
Nawajes A Mandal, Frankie Stentz, Peace Chiamaka Asuzu, Ebenezer Nyenwe, Jim Wan, Samuel Dagogo-Jack
Plasma sphingolipid profile of healthy black and white adults differs based on their parental history of type 2 diabetes. The Journal of clinical endocrinology and metabolism (2023)
Ambarish Pandey, Ahmed A Kolkailah, Francesco Cosentino, Christopher P Cannon, Robert C Frederich, David Z I Cherney, Samuel Dagogo-Jack, Richard E Pratley, Nilo B Cater, Ira Gantz, James P Mancuso, Darren K McGuire
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial. European heart journal (2023)
Samuel Dagogo-Jack, Robert Frederich, Jie Liu, Christopher P Cannon, Harry Shi, David Z I Cherney, Francesco Cosentino, Urszula Masiukiewicz, Ira Gantz, Richard E Pratley
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV. The Journal of clinical endocrinology and metabolism (2023)
Nawajes Mandal, Peace Asuzu, Frankie Stentz, Jim Wan, Samuel Dagogo-Jack
Ceramides and other sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics. Experimental biology and medicine (Maywood, N.J.) (2023)
Samuel Dagogo-Jack, Robert Frederich, Jie Liu, Christopher P Cannon, Harry Shi, David Z I Cherney, Francesco Cosentino, Urszula Masiukiewicz, Ira Gantz, Richard E Pratley
Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV. The Journal of clinical endocrinology and metabolism (2023)
Samuel Dagogo-Jack
Leptin and Insulin Sensitivity: Endogenous Signals of Metabolic Homeostasis. The Journal of clinical endocrinology and metabolism (2023)
Javier Morales, Samuel Dagogo-Jack, Vivian Fonseca, Joshua J Neumiller, Sylvia E Rosas
Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach. Clinical diabetes : a publication of the American Diabetes Association 41 (4) (2023)
Samuel Dagogo-Jack, Christopher P Cannon, David Z I Cherney, Francesco Cosentino, Jie Liu, Annpey Pong, Ira Gantz, Robert Frederich, James P Mancuso, Richard E Pratley
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose-lowering agent: An analysis from VERTIS CV. Diabetes, obesity & metabolism 24 (7) (2022)
Samuel Dagogo-Jack, Nkiru Umekwe, Amy A Brewer, Ibiye Owei, Vamsee Mupparaju, Renate Rosenthal, Jim Wan
Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study. BMJ open diabetes research & care 10 (2) (2022)
Ibiye Owei, Nkiru Umekwe, Frankie Stentz, Jim Wan, Samuel Dagogo-Jack
Association of plasma acylcarnitines with insulin sensitivity, insulin secretion, and prediabetes in a biracial cohort. Experimental biology and medicine (Maywood, N.J.) 246 (15) (2021)
Sareh Keshavarzi, Barbara H Braffett, Pradipta R Ray, Trevor J Orchard, Elsayed Z Soliman, Gayle M Lorenzi, Annette Barnie, Amy B Karger, Rose A Gubitosi-Klug, Samuel Dagogo-Jack, Andrew D Paterson, null null
Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study. Diabetes care 44 (5) (2021)
Ionut Bebu, Sareh Keshavarzi, Xiaoyu Gao, Barbara H Braffett, Angelo J Canty, William H Herman, Trevor J Orchard, Samuel Dagogo-Jack, David M Nathan, John M Lachin, Andrew D Paterson, null null
Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes care 44 (6) (2021)
Elizabeth Arquin Walker, Jeffrey S Gonzalez, Mark T Tripputi, Samuel Dagogo-Jack, Margaret J Matulik, Maria G Montez, Sameh Tadros, Sharon L Edelstein, null null
Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study. BMJ open diabetes research & care 8 (1) (2021)
Samuel Dagogo-Jack, Amy A Brewer, Ibiye Owei, Lindsey French, Nkiru Umekwe, Renate Rosenthal, Jim Wan
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) Study: design of lifestyle intervention. BMJ open diabetes research & care 8 (1) (2021)
Amoge Opara, Alec Jost, Samuel Dagogo-Jack, Emmanuel C Opara
Islet cell encapsulation - Application in diabetes treatment. Experimental biology and medicine (Maywood, N.J.) 246 (24) (2021)
Tibor V Varga, Jinxi Liu, Ronald B Goldberg, Guannan Chen, Samuel Dagogo-Jack, Carlos Lorenzo, Kieren J Mather, Xavier Pi-Sunyer, Søren Brunak, Marinella Temprosa, null null
Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program. BMJ open diabetes research & care 9 (1) (2021)
Samuel Dagogo-Jack, Richard E Pratley, David Z I Cherney, Darren K McGuire, Francesco Cosentino, Weichung J Shih, Jie Liu, Robert Frederich, James P Mancuso, Annaswamy Raji, Ira Gantz
Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial. BMJ open diabetes research & care 9 (1) (2021)
Nkiru Umekwe, Ibiye Owei, Frankie Stentz, Samuel Dagogo-Jack
Plasma FGF-21 and Sclerostin Levels, Glycemia, Adiposity, and Insulin Sensitivity in Normoglycemic Black and White Adults. Journal of the Endocrine Society 6 (1) (2021)
Samuel Dagogo-Jack
Prevention begets prevention - lessons from the Da Qing Study. Nature reviews. Endocrinology 15 (8) (2020)
Anthony Sallar, Samuel Dagogo-Jack
Regression from prediabetes to normal glucose regulation: State of the science. Experimental biology and medicine (Maywood, N.J.) 245 (10) (2020)
Barbara H Braffett, Samuel Dagogo-Jack, Ionut Bebu, William I Sivitz, Mary Larkin, Orville Kolterman, John M Lachin, null null
Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664. Diabetes care 42 (8) (2020)
Zsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, Brandy M Heckman-Stoddard, Christine G Lee, Samuel Dagogo-Jack, Jane F Ferguson, Richard F Hamman, William C Knowler, Kieren J Mather, Leigh Perreault, Jose C Florez, Thomas J Wang, Clary Clish, Marinella Temprosa, Robert E Gerszten, null null
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program. Diabetes 68 (12) (2019)
Leigh Perreault, David M Nathan, Emily B Schroeder, Rita R Kalyani, George A Bray, Samuel Dagogo-Jack, Neil H White, Ronald B Goldberg, Steven E Kahn, William C Knowler, Nestoras Nicolas Mathioudakis, Dana M Dabelea, null null
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes care 42 (9) (2019)
Barbara H Braffett, Samuel Dagogo-Jack, Ionut Bebu, William I Sivitz, Mary Larkin, Orville Kolterman, John M Lachin, null null
Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes care 42 (4) (2019)
Justin Basile Echouffo-Tcheugui, Stanford E Mwasongwe, Mario Sims, Samuel Dagogo-Jack, Sherita H Golden, Adolfo Correa, Solomon K Musani
Sickle Cell Trait, European Ancestry, and Longitudinal Tracking of HbA1c Among African Americans: The Jackson Heart Study. Diabetes care 42 (10) (2019)
Ebenezer A Nyenwe, Cherechi C Ogwo, Ibiye Owei, Jim Y Wan, Samuel Dagogo-Jack
Parental history of type 2 diabetes is associated with lower resting energy expenditure in normoglycemic subjects. BMJ open diabetes research & care 6 (1) (2018)
Ibiye Owei, Nkiru Umekwe, Casey Provo, Jim Wan, Samuel Dagogo-Jack
Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort. BMJ open diabetes research & care 5 (1) (2017)